Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore

Last edition

Home › News › Market

Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore

Dr Lal PathLabs Limited, a leading diagnostic and related healthcare service provider posted 31% dip in net profit at Rs. 32.6 crore for the fourth quarter ended March 31, 2020 as compared to Rs. 47.4 crore in Q4 last year.

The company's operating revenue increased by 0.2% in Q4 FY20 to Rs. 301.7 crore as against Rs. 301.1 crore in the previous year same quarter.

The normalised EBITDA for Q4 FY20 was at Rs. 55.5 crore as against Rs. 72.9 crore in the same quarter last year.

Read more on:
Dr Lal PathLabs Q4 net profit Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6

More news about: market | Published by Darshana | May - 19 - 2020 | 369

Last news about this category

Rubicon Research to Launch IPO on 9 October; Price Band Set at INR 461- INR 485 Per Share

Roche Pharma to Invest 1.5 Billion Swiss Francs in India Over Five Years, Boosting R&D and Access

Virupaksha Organics Files Draft Papers with SEBI for INR 740 Crore IPO

Testo Saveris to Showcase Comprehensive Pharma Monitoring System at CPHI 2025

India's Pharma Exports Set to Cross USD 30 Billion by Year-End: Dr Jitendra Singh

Novo Nordisk to Launch Ozempic in India

GlobalData's AI Tool Predicts Pharmaceutical Drug Approvals with 85 Percent Success Rate

Trump's 100 Percent Pharma Tariff to Have Twofold Impact on Indian Drugmakers

Anbenitamab Set to Lead as First Bispecific mAb in China's HER2+ Gastric Cancer Market: GlobalData

Vidal Health and SII Collaborate on HPV Vaccine Access

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy